Rhythm Pharmaceuticals, Inc. (RYTM) stock analysis

In our weekly check, Rhythm Pharmaceuticals, Inc. is graded D (A to F). Of 23 checks on debt, profit, cash flow and trend: 10 pass, warnings: 3, red flags: 10.

About Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as RYTM.

What our checks show for RYTM

Red flags

Warning signs

Strengths

Similar companies

CYTK · ABVX · AXSM · PTGX · TWST · ORKA

Questions

What grade does Rhythm Pharmaceuticals, Inc. (RYTM) have?

In our weekly check, Rhythm Pharmaceuticals, Inc. is graded D (A to F). Of 23 checks on debt, profit, cash flow and trend: 10 pass, warnings: 3, red flags: 10. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of RYTM stock?

This week's biggest flags for Rhythm Pharmaceuticals, Inc.: Weak interest cover, Weak EPS growth, Thin margins. In total 13 of 23 checks show a warning or a red flag.

What does Rhythm Pharmaceuticals, Inc. do?

Rhythm Pharmaceuticals, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as RYTM.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis